Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn J Caster

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Glomerular Diseases|August 11, 2025
Serum NF-κB-Regulated Biomarkers of Proliferative Lupus NephritisNicholas A Shoctor, Makayla P Brady, Rebecca R Lightman, et al.
American Journal of Physiology. Renal Physiology|May 24, 2018
Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritisDawn J Caster, Erik A Korte, Min Tan, et al.
Proteomics. Clinical Applications|April 1, 2015
Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritisDawn J Caster, Erik A Korte, Michael L Merchant, et al.
Arthritis Care & Research|August 30, 2022
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus NephritisCristina Arriens, Y K Onno Teng, Ellen M Ginzler, et al.
Lancet (London, England)|May 10, 2021
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialBrad H Rovin, Y K Onno Teng, Ellen M Ginzler, et al.
Journal of Clinical Medicine|March 6, 2021
Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin ExpressionDawn J Caster, Erik A Korte, Michael L Merchant, et al.
The American Journal of Pathology|September 23, 2017
ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular InflammationErik A Korte, Dawn J Caster, Michelle T Barati, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2023
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical TrialAmit Saxena, Ellen M Ginzler, Keisha Gibson, et al.
Journal of the American Society of Nephrology : JASN|June 21, 2020
Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental GlomerulosclerosisMichael L Merchant, Michelle T Barati, Dawn J Caster, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder WorkshopsSimon A Carter, Liz Lightstone, Dan Cattran, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Glomerular Diseases|August 11, 2025
Serum NF-κB-Regulated Biomarkers of Proliferative Lupus NephritisNicholas A Shoctor, Makayla P Brady, Rebecca R Lightman, et al.
American Journal of Physiology. Renal Physiology|May 24, 2018
Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritisDawn J Caster, Erik A Korte, Min Tan, et al.
Proteomics. Clinical Applications|April 1, 2015
Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritisDawn J Caster, Erik A Korte, Michael L Merchant, et al.
Arthritis Care & Research|August 30, 2022
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus NephritisCristina Arriens, Y K Onno Teng, Ellen M Ginzler, et al.
Lancet (London, England)|May 10, 2021
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialBrad H Rovin, Y K Onno Teng, Ellen M Ginzler, et al.
Journal of Clinical Medicine|March 6, 2021
Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin ExpressionDawn J Caster, Erik A Korte, Michael L Merchant, et al.
The American Journal of Pathology|September 23, 2017
ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular InflammationErik A Korte, Dawn J Caster, Michelle T Barati, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2023
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical TrialAmit Saxena, Ellen M Ginzler, Keisha Gibson, et al.
Journal of the American Society of Nephrology : JASN|June 21, 2020
Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental GlomerulosclerosisMichael L Merchant, Michelle T Barati, Dawn J Caster, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder WorkshopsSimon A Carter, Liz Lightstone, Dan Cattran, et al.
Pageof 4